Assessment of Risks and Benefits of Using Antibiotics Resistance Genes in Mesenchymal Stem Cell-Based Ex-Vivo Therapy

Recently, ex-vivo gene therapy has emerged as a promising approach to enhance the therapeutic potential of mesenchymal stem cells (MSCs) by introducing functional genes in vitro. Here, we explored the need of using selection markers to increase the gene delivery efficiency and evaluated the potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashyal, Narayan, Lee, Young Jun, Jung, Jin-Hwa, Kim, Min Gyeong, Lee, Kwang-Wook, Hwang, Woo Sup, Kim, Sung-Soo, Chang, Da-Young, Suh-Kim, Haeyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2023
Materias:
Technical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686797/
https://www.ncbi.nlm.nih.gov/pubmed/37385638
http://dx.doi.org/10.15283/ijsc23053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686797/
https://www.ncbi.nlm.nih.gov/pubmed/37385638
http://dx.doi.org/10.15283/ijsc23053

Ejemplares similares